Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective ligands of the Cannabinoid Type 2 Receptor.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
Reply to the Comment by Yolcu et al. on Our Paper Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
Disability status and dental pathology in multiple sclerosis patients.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Higher Blood Pressure Partially Links Greater Adiposity to Reduced Brain White Matter Integrity.
The role of myelin and oligodendrocytes in axonal energy metabolism.
Behçet's syndrome: a critical digest of the 2012-2013 literature.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.
Acute disseminated encephalomyelitis: case report and brief review.
Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages.
The Role of Ion Channels in Microglial Activation and Proliferation - A Complex Interplay between Ligand-Gated Ion Channels, K(+) Channels, and Intracellular Ca(2.).
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
[Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].
Small Molecule Inhibitor of Antigen Binding and Presentation by HLA-DR2b as a Therapeutic Strategy for the Treatment of Multiple Sclerosis.
A white matter lesion-filling approach to improve brain tissue volume measurements.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
Pages
« first
‹ previous
…
705
706
707
708
709
710
711
712
713
…
next ›
last »